# A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors

> **NCT04467853** · PHASE1 · TERMINATED · sponsor: **Shanghai East Hospital** · enrollment: 34 (actual)

## Conditions studied

- Solid Tumors, Adult

## Interventions

- **BIOLOGICAL:** LCAR-C18S cells

## Key facts

- **NCT ID:** NCT04467853
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-21
- **Primary completion:** 2023-07-17
- **Final completion:** 2023-07-17
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Both the sponsors and collaborator are considering terminating the study
- **Last updated:** 2023-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467853, "A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04467853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*